🇺🇸 Briplatin in United States
164 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 164
Most-reported reactions
- Diarrhoea — 22 reports (13.41%)
- Nausea — 19 reports (11.59%)
- Platelet Count Decreased — 17 reports (10.37%)
- Anaemia — 16 reports (9.76%)
- White Blood Cell Count Decreased — 16 reports (9.76%)
- Disseminated Intravascular Coagulation — 15 reports (9.15%)
- Interstitial Lung Disease — 15 reports (9.15%)
- Pulmonary Embolism — 15 reports (9.15%)
- Sepsis — 15 reports (9.15%)
- Product Use Issue — 14 reports (8.54%)
Other Other approved in United States
Frequently asked questions
Is Briplatin approved in United States?
Briplatin does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Briplatin in United States?
Hokkaido Gastrointestinal Cancer Study Group is the originator. The local marketing authorisation holder may differ — check the official source linked above.